Germany Gastric Cancer Diagnostics Market to 2032
Overview
The Germany Gastric Cancer Diagnostics Market is expected to reach a 125.55 USD Million by 2032 and is projected to grow at a CAGR of 13.72% from 2025 to 2032.
Germany Gastric Cancer Diagnostics Market 2018-2032 USD Million
Germany Gastric Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 61.53 USD Million
- Projected Market Size (2032): 125.55 USD Million
- CAGR (2025-2032): 13.72%
Key Findings of Germany Gastric Cancer Diagnostics Market
- The Germany Gastric Cancer Diagnostics Market was valued at 61.53 USD Million in 2024.
- The Germany Gastric Cancer Diagnostics Market is likely to grow at a CAGR of 13.72% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 39.14 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 16.87% during the forecast period from 2024 to 2032.
Germany Gastric Cancer Diagnostics Market Scope
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
- Pediatric
- Adult
- Geriatrics
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
- Stage 0
- Stage III
- Stage II
- Stage I
- Services
- Instruments
- Reagents & Consumables
- Female
- Male
- Urine
- Blood
- Tissue
- Stool
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
- Retail Sales
- Direct Tender
Germany Gastric Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 61.53 USD Million |
| Market Value in 2032 | 125.55 USD Million |
| CAGR (2025-2032) | 13.72% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Diagnostic Type,Age Group,Disease Type,Stage,Product Type,Gender,Sample Type,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Germany, leading in terms of revenue 61.53 USD Million in 2024
- Key Country: Germany, leading in terms of revenue with value of 61.53 USD Million in 2024.
Segments and Scope
-
Germany Gastric Cancer Diagnostics Market to 2032, By Diagnostic Type
- Confirmatory Test is the largest segment in Germany Gastric Cancer Diagnostics Market to 2032 with a revenue of 35.57 USD Million in the year 2024.
- Confirmatory Test is the Fastest growing segment in Germany Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 14.76 % in forecast period 2025-2032.
-
Germany Gastric Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in Germany Gastric Cancer Diagnostics Market to 2032 with a revenue of 32.85 USD Million in the year 2024.
- Geriatrics is the Fastest growing segment in Germany Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.80 % in forecast period 2025-2032.
-
Germany Gastric Cancer Diagnostics Market to 2032, By Disease Type
- Intestinal or Diffuse Adinocarcinoma is the largest segment in Germany Gastric Cancer Diagnostics Market to 2032 with a revenue of 26.77 USD Million in the year 2024.
- Intestinal or Diffuse Adinocarcinoma is the Fastest growing segment in Germany Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 16.05 % in forecast period 2025-2032.
-
Germany Gastric Cancer Diagnostics Market to 2032, By Stage
- Stage I is the largest segment in Germany Gastric Cancer Diagnostics Market to 2032 with a revenue of 23.25 USD Million in the year 2024.
- Stage I is the Fastest growing segment in Germany Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 16.27 % in forecast period 2025-2032.
-
Germany Gastric Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in Germany Gastric Cancer Diagnostics Market to 2032 with a revenue of 34.21 USD Million in the year 2024.
- Reagents & Consumables is the Fastest growing segment in Germany Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.71 % in forecast period 2025-2032.
-
Germany Gastric Cancer Diagnostics Market to 2032, By Gender
- Male is the largest segment in Germany Gastric Cancer Diagnostics Market to 2032 with a revenue of 33.37 USD Million in the year 2024.
- Male is the Fastest growing segment in Germany Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.08 % in forecast period 2025-2032.
-
Germany Gastric Cancer Diagnostics Market to 2032, By Sample Type
- Stool is the largest segment in Germany Gastric Cancer Diagnostics Market to 2032 with a revenue of 25.11 USD Million in the year 2024.
- Stool is the Fastest growing segment in Germany Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 16.80 % in forecast period 2025-2032.
-
Germany Gastric Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Germany Gastric Cancer Diagnostics Market to 2032 with a revenue of 21.42 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Germany Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 16.87 % in forecast period 2025-2032.
-
Germany Gastric Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Germany Gastric Cancer Diagnostics Market to 2032 with a revenue of 39.14 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Germany Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 14.74 % in forecast period 2025-2032.
Germany Gastric Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| BIOMÉRIEUX | |||
| Abbott | |||
| General Electric | |||
| F. Hoffmann-La Roche Ltd. | |||
Germany Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Germany Gastric Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Germany Gastric Cancer Diagnostics Market Scope
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
- Pediatric
- Adult
- Geriatrics
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
- Stage 0
- Stage III
- Stage II
- Stage I
- Services
- Instruments
- Reagents & Consumables
- Female
- Male
- Urine
- Blood
- Tissue
- Stool
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
- Retail Sales
- Direct Tender
Frequently Asked Questions
Germany Gastric Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.